Helen Fisher

Helen Fisher

Direttore/Membro del Consiglio presso CALIX LIMITED

Patrimonio netto: 58 873 $ in data 31/05/2026

Commercial Services
Consumer Services
Health Technology

Profilo

Helen Fisher is currently the Managing Director & CEO at BCIF Pty Ltd., the Chairman-Victorian Branch at AusBiotech Ltd., an Independent Non-Executive Director at Calix Ltd., a Member of Chartered Accountants Australia & New Zealand, and a Member of The American Chamber of Commerce in Australia.
Previously, she served as an Independent Non-Executive Director at Sienna Cancer Diagnostics Ltd. from 2018 to 2020, a Non-Executive Director at INOVIQ Ltd. in 2020, and an Independent Non-Executive Director at Paradigm Biopharmaceuticals Ltd. from 2021 to 2024.
She also worked as a Partner at Deloitte & Touche (Australia).
Ms. Fisher holds graduate degrees from the University of Melbourne and The University of New South Wales.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
05/12/2025 168.710 ( 0,08% ) 58 873 $ 31/05/2026

Posizioni attive di Helen Fisher

SocietàPosizioneInizio
CALIX LIMITED Direttore/Membro del Consiglio 22/09/2020
Amministratore Delegato -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Helen Fisher

SocietàPosizioneFine
PARADIGM BIOPHARMACEUTICALS LIMITED Direttore/Membro del Consiglio 04/03/2024
INOVIQ LTD Direttore/Membro del Consiglio 25/11/2020
SIENNA CANCER DIAGNOSTICS LIMITED Direttore/Membro del Consiglio 01/07/2020
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Helen Fisher

Formazione di Helen Fisher

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

94

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Producer Manufacturing

Health Technology

Commercial Services

Finance

Health Services

Finance

  1. Mercati
  2. Insiders
  3. Helen Fisher
-40%: Proroga eccezionale
g
:
:
ENTRA ORA